Description

Casodex, Cosudex (Bicalutamide) This medicine is an anti-androgen used in combination with another medicine to treat prostate cancer. Before using Some medicines or medical conditions may interact with this medicine.

 

	Quantity	Strength	Price
	10 Tab(s)	50mg	$32.00
	30 Tab(s)	50mg	$95.00
	40 Tab(s)	50mg	$127.00
	60 Tab(s)	50mg	$190.00
	80 Tab(s)	50mg	$253.00
	90 Tab(s)	50mg	$284.00

INDICATIONS CASODEX 50 mg daily is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analogue for the treatment of Stage D2 metastatic carcinoma of the prostate. CASODEX 150 mg daily is not approved for use alone or with other treatments. See CLINICAL PHARMACOLOGY-Clinical Studies- Safety Data from Clinical Studies using CASODEX 150 mg section for additional important safety information regarding CASODEX 150 mg. DOSAGE AND ADMINISTRATION The recommended dose for CASODEX therapy in combination with an LHRH analogue is one 50 mg tablet once daily (morning or evening), with or without food. It is recommended that CASODEX be taken at the same time each day. Treatment with CASODEX should be started at the same time as treatment with an LHRH analogue. Dosage Adjustment in Renal Impairment: No dosage adjustment is necessary for patients with renal impairment (see CLINICAL PHARMACOLOGY, Special Populations, Renal Insufficiency). Dosage Adjustment in Hepatic Impairment: No dosage adjustment is necessary for patients with mild to moderate hepatic impairment. Although there is a 76% (5.9 and 10.4 days for normal and impaired patients, respectively) increase in the half-life of the active enantiomer of bicalutamide in patients with severe liver impairment (n=4), no dosage adjustment is necessary (see CLINICAL PHARMACOLOGY, Special Populations, Hepatic Impairment, PRECAUTIONS and WARNINGS sections).